Skip to main content
logo
Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
23.20
-4.10 (-15.02%)
At close: Jan 12, 2026, 4:00 PM EST
23.34
+0.14 (0.60%)
After-hours: Jan 12, 2026, 7:57 PM EST

Apellis Pharmaceuticals Employees

As of December 31, 2024, Apellis Pharmaceuticals had 710 total employees, including 705 full-time and 5 part-time employees. The number of employees increased by 4 or 0.57% compared to the previous year.

Employees
710
Change (1Y)
4
Growth (1Y)
0.57%
Revenue / Employee
$1,431,545
Profits / Employee
$63,361
Market Cap
2.94B

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 202471040.57%
Dec 31, 2023706-61-7.95%
Dec 31, 202276729161.13%
Dec 31, 202147610227.27%
Dec 31, 202037413959.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Related Stocks

Company NameEmployees
UnitedHealth Group400,000
Johnson & Johnson138,100
Thermo Fisher Scientific125,000
Abbott Laboratories114,000
AstraZeneca92,900
Novo Nordisk77,349
Novartis AG75,883
Merck & Co.75,000
Employee Rankings

APLS News

More News